Deadline Alert: Investors to Act in Outset Medical Class Action Lawsuit

Investors are urged to take note as the deadline for participation in a class action lawsuit against Outset Medical, Inc. OM is approaching. Glancy Prongay & Murray LLP (GPM), a prominent law firm advocating for the rights of investors, has issued a reminder that October 28, 2024, is the last day for eligible investors to file a lead plaintiff motion. This lawsuit concerns those who have purchased or acquired shares of Outset Medical, a company specializing in the development of an innovative hemodialysis system, which is headquartered in San Jose, California.

Understanding the Class Action Suit

The class action lawsuit filed by GPM alleges that Outset Medical may have provided misleading information to its shareholders, potentially harming their investments. Shareholders who acted on the company's information between specific dates and suffered losses are therefore encouraged to participate in the lawsuit. The case seeks to recover damages on their behalf and hold Outset Medical accountable for any perceived discrepancies in its disclosure practices.

What This Means for OM Shareholders

Shareholders of OM who meet the requirements and wish to serve as the lead plaintiff must move the court no later than October 28, 2024. It's essential for such shareholders to assert their rights and influence the direction of the lawsuit. Those who do not meet the deadline for the lead plaintiff role can still remain class members and may still be eligible for any potential recovery should the case be successful.

deadline, lawsuit, investors